Kintegral Advisory LLC Sells 803 Shares of Agilent Technologies, Inc. (NYSE:A)

Kintegral Advisory LLC reduced its position in Agilent Technologies, Inc. (NYSE:A) by 4.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,243 shares of the medical research company’s stock after selling 803 shares during the quarter. Kintegral Advisory LLC’s holdings in Agilent Technologies were worth $2,321,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. AMF Tjanstepension AB acquired a new position in shares of Agilent Technologies during the 3rd quarter worth $2,726,000. International Assets Investment Management LLC bought a new position in Agilent Technologies in the third quarter valued at about $12,961,000. Assenagon Asset Management S.A. raised its stake in Agilent Technologies by 173.6% during the third quarter. Assenagon Asset Management S.A. now owns 27,113 shares of the medical research company’s stock worth $4,026,000 after acquiring an additional 17,203 shares in the last quarter. Ballentine Partners LLC lifted its holdings in shares of Agilent Technologies by 7.7% in the third quarter. Ballentine Partners LLC now owns 2,732 shares of the medical research company’s stock worth $406,000 after acquiring an additional 195 shares during the last quarter. Finally, Lake Street Advisors Group LLC lifted its holdings in shares of Agilent Technologies by 2.9% in the third quarter. Lake Street Advisors Group LLC now owns 3,295 shares of the medical research company’s stock worth $489,000 after acquiring an additional 94 shares during the last quarter.

Agilent Technologies Price Performance

Shares of A opened at $135.33 on Friday. The business has a 50-day moving average of $140.97 and a 200-day moving average of $139.31. Agilent Technologies, Inc. has a 1 year low of $124.16 and a 1 year high of $155.35. The company has a market capitalization of $38.61 billion, a price-to-earnings ratio of 30.62, a price-to-earnings-growth ratio of 3.67 and a beta of 1.07. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.41 by $0.05. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The firm had revenue of $1.70 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the previous year, the company earned $1.38 EPS. The company’s revenue for the quarter was up .8% on a year-over-year basis. As a group, equities research analysts anticipate that Agilent Technologies, Inc. will post 5.56 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be given a $0.248 dividend. This represents a $0.99 annualized dividend and a dividend yield of 0.73%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.40%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on A shares. Bank of America decreased their price target on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a report on Friday, December 13th. Wells Fargo & Company decreased their target price on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a research note on Monday, December 9th. Sanford C. Bernstein lowered their price target on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a report on Tuesday, November 26th. Citigroup raised their price objective on Agilent Technologies to $165.00 and gave the company a “buy” rating in a report on Thursday, December 19th. Finally, StockNews.com raised Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Seven research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $144.38.

Insider Activity

In other news, CEO Padraig Mcdonnell sold 1,911 shares of the firm’s stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the sale, the chief executive officer now owns 39,652 shares of the company’s stock, valued at $5,947,800. This trade represents a 4.60 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.